Cingulate CINGW
NASDAQ CINGW
$0.01 +0.00 (+4.29%)
As of: Sep 9, 2026 · 11:16 AM EDT

Cingulate (CINGW) Tax Provisions (2022 - 2026)

Cingulate's (CINGW) quarterly Tax Provisions came in at -$1.2 million in Q2 2026, down 18.02% on a YoY basis from -$1.5 million in Q2 2025, and up 6.52% quarter-over-quarter from -$1.3 million in Q4 2025.

Analysis

Cingulate (CINGW) Tax Provisions (2022 - 2026) Analysis & Trends

Cingulate (CINGW) has reported Tax Provisions for 5 consecutive years, with -$1.2 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Tax Provisions fell 18.02% year-over-year to -$1.2 million; the trailing twelve-month figure through Jun 2026 stood at -$5.1 million (down 27.87% YoY), and the FY2025 full-year result was -$4.7 million, down 35.56% from the prior year.
  • Tax Provisions rose to -$1.2 million in Q2 2026 per CINGW's latest filing, from -$1.3 million in the prior quarter.
  • Across five years, Tax Provisions topped out at -$588266.0 in Q1 2024 and bottomed at -$1.5 million in Q3 2025.
  • Historically, Tax Provisions has averaged -$1.1 million across 5 years, with a median of -$1.0 million in 2022.
  • The sharpest annual moves came in 2024 and 2025: Tax Provisions jumped 48.9% in 2024, then slumped 77.94% in 2025.
  • Over 5 years, Tax Provisions stood at -$978229.0 in 2022, then sank by 48.27% to -$1.5 million in 2023, then increased by 9.78% to -$1.3 million in 2024, then declined by 0.79% to -$1.3 million in 2025, then grew by 6.52% to -$1.2 million in 2026.
  • According to Business Quant data, Tax Provisions over the past three periods registered -$1.2 million, -$1.3 million, and -$1.5 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Johnson & Johnson 644.70 Bn 623.94 Bn 17.26 Bn 1.21 Bn
2 AbbVie 441.16 Bn 434.59 Bn 12.70 Bn 662.00 Mn
3 Merck 364.92 Bn 357.78 Bn 12.21 Bn 654.00 Mn
4 Novartis Ag 266.48 Bn 258.79 Bn 11.24 Bn -1.01 Bn
5 Pfizer 159.03 Bn 147.33 Bn 10.94 Bn -407.00 Mn
6 Sanofi 52.53 Bn 45.15 Bn 10.79 Bn -524.23 Mn
7 Revolution Medicines 44.20 Bn 44.20 Bn - -
8 Incyte 25.27 Bn 20.74 Bn 1.57 Bn 165.91 Mn
9 United Therapeutics 21.44 Bn 18.78 Bn 683.80 Mn 39.70 Mn
10 Cingulate 100,214.03 100,214.03 - -1.23 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.23 Mn
Dec 31, 2025 -1.32 Mn
Sep 30, 2025 -1.54 Mn
Jun 30, 2025 -1.04 Mn
Mar 31, 2025 -798,576.00
Dec 31, 2024 -1.31 Mn
Sep 30, 2024 -866,387.00
Jun 30, 2024 -709,986.00
Mar 31, 2024 -588,266.00
Dec 31, 2023 -1.45 Mn
Sep 30, 2023 -1.26 Mn
Jun 30, 2023 -1.39 Mn
Mar 31, 2023 -841,026.00
Dec 31, 2022 -978,229.00
Sep 30, 2022 -845,722.00
Jun 30, 2022 -848,475.00
Mar 31, 2022 -1.04 Mn